[癌ワクチン]TroVax

Oxford BioMedica社
癌ワクチン・TroVax
効いているんだろうか？

BioToday - 癌ワクチン・TroVaxに対する免疫応答と生存が関連する
Cancer Vaccine Shows Promise In Patients With Bowel, Kidney And Prostate Cancer
OxfordBiomedica-TroVax

20th EORTC-NCI-AACR

TroVax is made up of a modified virus (Modified Vaccinia Ankara (MVA)), which acts as a vehicle to transport a second component, a gene that produces an antigen that is present in most solid tumours, called 5T4. TroVax is injected into patients whose solid tumours have the 5T4 tumour antigen present, so that the vaccine can trigger the body's natural immune responses to mobilise against 5T4.

ECCO-the European CanCer Organisation (2008, October 26). Cancer Vaccine Shows Promise In Patients With Bowel, Kidney And Prostate Cancer. ScienceDaily. Retrieved October 26, 2008, from http://www.sciencedaily.com­ /releases/2008/10/081023195220.htm